id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1862962,cae19085-e954-4422-bbd4-04d71a0de764,Q2,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,27478,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,2016,second_quarter,PHA,"H.R. 244 - MAC Transparency Act of 2015; 
Congressional Oversight of 340 B Program;
S. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act;
Issues related to FDA implementation of The Drug Quality and Security Act related to compounding;
Issues Related to Direct and Indirect Renumeration (DIR) Fees","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Natl Drug Control Policy (NDCP),Office of Personnel Management (OPM),SENATE",,390000,0,0,2016-07-20T15:31:54.777000-04:00